DaicelFRA:9DC +2.84%82 EBITDA Margin % is 12.50% as of Mar. 2026, which is 28% below its 10-year median of 17.42. GuruFocus rates FRA:9DC with a GF Score™ of 82/100 and a GF Value™ of €8.06 (Modestly Undervalued). The stock has 8 warning signs investors should review. Among 1,585 Chemicals companies, Daicel ranks better than 61.39% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Daicel's EBITDA for the
three
months ended in Mar. 2026 was €105 Mil. Daicel's Revenue for the
three
months ended in Mar. 2026 was €844 Mil. Therefore, Daicel's EBITDA margin for the quarter that ended in Mar. 2026 was 12.50%.
Daicel (FRA:9DC) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Daicel EBITDA Margin % Related Terms
Daicel EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Daicel's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:9DC vs LIN, SHW, ECL: EBITDA Margin % Comparison
For the Specialty Chemicals subindustry, Daicel's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Daicel EBITDA Margin % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Daicel's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Daicel's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Daicel (FRA:9DC) has a EBITDA Margin % of 12.50% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Daicel and its competitors. This is 28% below median its historical median of 17.42. Over the past decade, Daicel's EBITDA Margin % has ranged from 11.61 to 21.85. According to the industry distribution chart, Daicel ranks #612 out of 1585 companies in the Chemicals industry, placing it in the top 38.6%.
Is Daicel's EBITDA Margin % too high?
Daicel's current EBITDA Margin % of 12.50% is 28% below median its 10-year median of 17.42. Over the past 10 years, this metric has ranged from a low of 11.61 to a high of 21.85. The Chemicals industry median EBITDA Margin % is 9.63. Daicel's value of 12.50% is 29.8% above this industry median. Based on the distribution chart, Daicel ranks #612 out of 1585 companies in the Chemicals industry, which is above the industry midpoint. Overall, Daicel has a GF Score™ of 82/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Daicel's EBITDA Margin % compare to LIN and SHW?
According to the Chemicals industry distribution chart, Daicel ranks #612 out of 1585 companies for EBITDA Margin %. This puts Daicel in the upper half of its industry. The industry median EBITDA Margin % is 9.63. Daicel's value of 12.50% is 29.8% above this benchmark. Historically, Daicel's own EBITDA Margin % has ranged from 11.61 to 21.85 over the past decade. While the company's 10-year median is 17.42 vs. the industry median of 9.63, Daicel has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Chemicals company?
The median EBITDA Margin % among Chemicals companies is 9.63, based on 1,585 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Daicel's current EBITDA Margin % of 12.50% is 29.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Daicel and its competitors. For the Chemicals industry, the median EBITDA Margin % is 9.63 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Daicel's current EBITDA Margin % is 12.50%, which is 28% below median its own 10-year median of 17.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Daicel stock overvalued right now?
Based on GuruFocus' analysis, Daicel (FRA:9DC) is currently considered Modestly Undervalued. The stock's GF Value™ is €8.06, compared to a current price of €7.25 — trading 10% below its estimated fair value. The current EBITDA Margin % is 12.50%, which is 28% below median its 10-year median of 17.42 and 29.8% above the Chemicals industry median of 9.63. Daicel's overall GF Score™ is 82/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Daicel (FRA:9DC), the current EBITDA Margin % is 12.50% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Daicel (FRA:9DC) Overvalued in 2026?
Based on GuruFocus' analysis, Daicel stock appears to be undervalued.
The current stock price of €7.25 is trading 10% below its estimated GF Value™ of €8.06.
GuruFocus considers Daicel to be Modestly Undervalued.
Key valuation signals for FRA:9DC:
EBITDA Margin %: 12.50% (28% below median its 10-year median of 17.42)
GF Value™: €8.06 vs. price of €7.25 (10% below fair value)
Industry Position: 29.8% above the Chemicals median (#612 of 1585)
No single metric tells the full story. See the FRA:9DC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Daicel Corp is a Japanese chemical company engaged in engineering plastics, materials, medical health care, safety, smart materials, & other businesses. The company operates through five segments. The Engineering Plastics segment includes polyacetal resins, PET resins, liquid crystal polymers, and related products. The Material segment covers acetic acid, derivatives, acetate tow, cellulose acetate, and cosmetic raw materials. The Medical Health Care segment provides enantiomer separation columns and health food materials. The Safety segment offers inflators for automobile airbags and circuit breakers, while the Smart segment handles caprolactone derivatives, epoxy compounds, semiconductor materials, and functional films. The Others segment includes membranes and transportation warehouses.
82GF Score
Get the complete analysis for FRA:9DC
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:9DC has been successfully added to your 
